Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
TTK HEALTHCARE ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
TTK HEALTHCARE Mar-23 |
ADCOCK INGRAM Jun-14 |
TTK HEALTHCARE/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,106 | 319 | - | |
Low | Rs | 668 | 230 | - | |
Sales per share (Unadj.) | Rs | 513.2 | 94.9 | - | |
Earnings per share (Unadj.) | Rs | 31.6 | -23.9 | - | |
Cash flow per share (Unadj.) | Rs | 40.7 | -19.8 | - | |
Dividends per share (Unadj.) | Rs | 10.00 | 0 | - | |
Avg Dividend yield | % | 1.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 674.7 | 74.5 | - | |
Shares outstanding (eoy) | m | 14.13 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.7 | 2.9 | 59.7% | |
Avg P/E ratio | x | 28.0 | -11.5 | -244.3% | |
P/CF ratio (eoy) | x | 21.8 | -13.9 | -157.3% | |
Price / Book Value ratio | x | 1.3 | 3.7 | 35.7% | |
Dividend payout | % | 31.6 | 0 | - | |
Avg Mkt Cap | Rs m | 12,529 | 46,340 | 27.0% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 1,234 | 2,908 | 42.4% | |
Avg. sales/employee | Rs Th | 0 | 3,730.7 | - | |
Avg. wages/employee | Rs Th | 0 | 677.5 | - | |
Avg. net profit/employee | Rs Th | 0 | -940.1 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 7,251 | 16,016 | 45.3% | |
Other income | Rs m | 483 | 112 | 430.9% | |
Total revenues | Rs m | 7,734 | 16,128 | 48.0% | |
Gross profit | Rs m | 313 | -2,775 | -11.3% | |
Depreciation | Rs m | 128 | 691 | 18.5% | |
Interest | Rs m | 52 | 434 | 12.1% | |
Profit before tax | Rs m | 616 | -3,788 | -16.3% | |
Minority Interest | Rs m | 0 | -11 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 170 | 237 | 71.7% | |
Profit after tax | Rs m | 447 | -4,036 | -11.1% | |
Gross profit margin | % | 4.3 | -17.3 | -24.9% | |
Effective tax rate | % | 27.5 | -6.2 | -440.6% | |
Net profit margin | % | 6.2 | -25.2 | -24.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 10,664 | 11,730 | 90.9% | |
Current liabilities | Rs m | 2,108 | 6,600 | 31.9% | |
Net working cap to sales | % | 118.0 | 32.0 | 368.4% | |
Current ratio | x | 5.1 | 1.8 | 284.7% | |
Inventory Days | Days | 13 | 111 | 11.5% | |
Debtors Days | Days | 464 | 124 | 374.1% | |
Net fixed assets | Rs m | 994 | 6,838 | 14.5% | |
Share capital | Rs m | 141 | 74 | 190.0% | |
Net worth | Rs m | 9,534 | 12,571 | 75.8% | |
Long term debt | Rs m | 0 | 4,418 | 0.0% | |
Total assets | Rs m | 11,658 | 23,747 | 49.1% | |
Interest coverage | x | 12.8 | -7.7 | -165.1% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.7 | 92.2% | |
Return on assets | % | 4.3 | -15.2 | -28.2% | |
Return on equity | % | 4.7 | -32.1 | -14.6% | |
Return on capital | % | 7.0 | -19.8 | -35.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -261 | 1,367 | -19.1% | |
From Investments | Rs m | 330 | -420 | -78.5% | |
From Financial Activity | Rs m | -124 | 4,009 | -3.1% | |
Net Cashflow | Rs m | -55 | 4,957 | -1.1% |
Compare TTK HEALTHCARE With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare TTK HEALTHCARE With: SUVEN PHARMACEUTICALS PANCHSHEEL ORG KWALITY PHARMA SHAMROCK IND WALPAR NUTRITIONS LTD.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.